companydata.dkcompanydata.dk
SearchPricingAPI
companydata.dkcompanydata.dk

Free company lookup with financials, ownership and key figures for all Danish companies.

Overview

  • Municipalities
  • Postal codes
  • Industries
  • Countries
  • Top 100 companies
  • Top lists
  • Business news
  • Check company
  • Find owner
  • Financial data
  • Credit rating
  • Credit report
  • Background check

Links

  • Search
  • Pricing
  • Company profile
  • Monitoring
  • Lead List Generator
  • Screening
  • CVR Enrichment
  • Network search
  • Statstidende
  • Guides
  • Glossary
  • Compare alternatives

Integrations

  • API
  • MCP-server
  • Claude
  • ChatGPT
  • Perplexity
  • Mistral Le Chat
  • Gemini
  • Zapier
  • Dinero
  • e-conomic

Who it's for

  • For you
  • For accountants
  • For investors
  • For sales teams
  • For lawyers
  • For journalists

Legal

  • Privacy Policy
  • Terms of Service
  • Information Letter
  • Contact

© 2026 companydata.dk

Jens-Nikolaj Schøier

PersonUnit number: 4004154475
København K
1
Ownership
8
Board positions
7
Director positions
6
Other roles
18
People in network

People in network(18)

People who held roles at the same companies, or who co-own the same companies

Mohammad Sohail Asghar
Frederiksstaden Pharma ApS, XGX Pharma ApS, XGX Pharma ApS, Vautia Therapeutics ApS
Rolf Eckersberg
Frederiksstaden Pharma ApS, Frederiksstaden Pharma ApS, XGX Pharma ApS
Lars Karlsmose
XGX Pharma ApS, HB MEDICAL SCANDINAVIA A/S, HB MEDICAL SCANDINAVIA A/S
Find the connection to another person

Ownership(1)

Schøier Holding ApS
CVR: 39182475
EJERREGISTER
100%
Ownership
Active

Director positions(3)

Frederiksstaden Pharma ApS
CVR: 25630483
DIREKTØR
Active
Since 5. maj 2022
Schøier Holding ApS
CVR: 39182475
DIREKTØR
Active
Since 21. dec. 2017
XGX Pharma ApS
CVR: 32289290
ADM. DIR.
Active
Since 1. dec. 2017

Other roles(2)

Schøier Holding ApS
CVR: 39182475
STIFTERE
Active
Since 21. dec. 2017
XGX Pharma ApS
CVR: 32289290
EJERREGISTER
Active

See the full network around Jens-Nikolaj Schøier

Map board positions, ownership and connections across every Danish company.

See what Pro offers

Former board positions(8)

Frederiksstaden Pharma ApS
CVR: 25630483
FORMAND
Ended
Since 19. dec. 2019
Until 5. maj 2022
HB MEDICAL SCANDINAVIA A/S
CVR: 37638862
BESTYRELSESMEDLEM
Dissolved
Ended
Since 2. dec. 2019
Until 2. dec. 2019
XGX Pharma ApS
CVR: 32289290
BESTYRELSESMEDLEM
Ended
Since 1. nov. 2018
Until 21. jul. 2025
ACTELION DANMARK, FILIAL AF ACTELION PHARMACEUTICALS SVERIGE AB, SVERIGE
CVR: 32478603
FILIALBESTYRERE
Dissolved
Ended
Since 1. dec. 2014
Until 26. jan. 2015
NS EJENDOMME ApS
CVR: 30507371
DIREKTION
Dissolved
Ended
Since 15. maj 2008
Until 11. jan. 2010
S-JN INVEST ApS
CVR: 31604044
DIREKTION
Dissolved
Ended
Since 15. maj 2008
Until 11. jan. 2010
NS HOLDING ApS
CVR: 30566130
DIREKTION
Dissolved
Ended
Since 24. apr. 2007
Until 19. jan. 2012
AGENTURET-KBH. ApS
CVR: 29395969
BESTYRELSE
Dissolved
Ended
Since 1. maj 2006
Until 19. jan. 2011

Former director positions(4)

HB MEDICAL SCANDINAVIA A/S
CVR: 37638862
DIREKTØR
Dissolved
Ended
Since 2. dec. 2019
Until 2. dec. 2019
KBH Kaffe Koncepter ApS
CVR: 39888890
ADM. DIR.
Dissolved
Ended
Since 19. sep. 2018
Until 21. aug. 2025
Fortunens Totalentreprise ApS
CVR: 39002825
ADM. DIR.
Dissolved
Ended
Since 1. nov. 2017
Until 19. dec. 2025
Razor Partners ApS
CVR: 31258871
DIREKTØR
Dissolved
Ended
Since 6. apr. 2008
Until 21. jun. 2011

Former roles(4)

Fortunens Totalentreprise ApS
CVR: 39002825
STIFTERE
Dissolved
Ended
Since 11. okt. 2017
Until 19. dec. 2025
NS EJENDOMME ApS
CVR: 30507371
STIFTERE
Dissolved
Ended
Since 15. maj 2008
Until 11. jan. 2010
S-JN INVEST ApS
CVR: 31604044
STIFTERE
Dissolved
Ended
Since 15. maj 2008
Until 11. jan. 2010
NS HOLDING ApS
CVR: 30566130
STIFTERE
Dissolved
Ended
Since 24. apr. 2007
Until 19. jan. 2012

Indirect ownership(1)

Companies owned indirectly through ownership chains.

Vautia Therapeutics ApS
CVR: 45465578
50-66,65%
Effective ownership
Depth: 1
Ownership path:
Schøier Holding ApS(100%)
→Vautia Therapeutics ApS(50-66,65%)